作者：
Regina,Barragan-Carrillo [1]
;
Eddy,Saad [2]
;
Renee-Maria,Saliby [2]
;
Maxine,Sun [2]
;
Laurence,Albiges [3]
;
Axel,Bex [4]
;
Daniel,Heng [5]
;
Arnaud,Mejean [6]
;
Robert J,Motzer [7]
;
Elizabeth R,Plimack [8]
;
Thomas,Powles [9]
;
Brian I,Rini [10]
;
Tian,Zhang [11]
;
Toni K,Choueiri [12]
作者单位：
Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
[1]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
[2]
Institut Gustave Roussy, Paris, France.
[3]
Specialist Centre for Kidney Cancer, Royal Free NHS Foundation Trust, University College London Division of Surgery and Interventional Science, London, UK.
[4]
Department of Oncology, Tom Baker Cancer Centre, Calgary, Canada.
[5]
Department of Urology, Hôpital Européen Georges Pompidou, Paris, France.
[6]
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[7]
Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
[8]
Barts Health NHS Trust and the Royal Free NHS Foundation Trust, Barts Cancer Institute, London, UK; Queen Mary University of London, London, UK.
[9]
Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
[10]
Division of Hematology and Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
[11]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: toni_choueiri@dfci.harvard.edu.
[12]
DOI
10.1016/j.eururo.2024.10.019
PMID
39505582
发布时间
2024-11-06
换一批
换一批
